最新医学別冊　新しい診断と治療のABC21/神経2　頭痛

出版社： 最新医学社
発行日： 2004-05-31
分野： 臨床医学：一般  >  雑誌
雑誌名：
電子書籍版： 2004-05-31
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

5,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

目次

  • 最新医学別冊　新しい診断と治療のABC21／神経２　頭痛

    ―目次―

    第１章　頭痛の概念・定義
    　新国際頭痛分類（ICHDﾐ?）−一次性頭痛，二次性頭痛−
    　頭痛の臨床疫学

    第２章　頭痛医療システム
    　頭痛外来
    　ペインクリニック
    　プライマリーケアと病診連携
    　職場，学校での頭痛対策
    　脳ドックの役割 PL
    　医療経済学

    第３章　頭痛の問診と診察
    　問診
    　問診アシストパッケージ
    　鑑別診断

    第４章　片頭痛
    　概念，分類と診断基準
    　発症のメカニズム
    　セロトニンの役割
    　急性期治療の手順：（1）薬物治療の種類
    　急性期治療の手順：（2）トリプタン製剤の至適使用法

    第５章　緊張型頭痛
    　分類と診断基準と病態
    　治療法

    第６章　群発頭痛
    　分類と診断基準
    　病態生理
    　治療法

    第７章　薬物乱用頭痛
    　予防対策と治療

    第８章　頭痛治療のガイドライン
    　頭痛治療ガイドライン（慢性頭痛治療ガイドライン 2002）

    座談会　頭痛医療の展望

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 頭痛の概念・定義

P.15 掲載の参考文献
1) The Ad Hoc Comittee on Calassification of Headache:Classification of headache. Arch Neurol 6:137-176, 1962.
 
2) Headache Classification Committee of the International Headache Society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache 8 (Suppl 7):1-96, 1988.
 
3) 荒木信夫:頭痛の分類. 内科81 (4):610-616, 1998.
 
4) Headache Classification Subcommittee of the International Headache Society:The International Classification of Headache Disorders:2nd Edition. Cephalalgia 24 (suppl 1):9-160, 2004.
 
5) 坂井文彦:新しい国際頭痛分類 (ICHD-II). CLINICLAN 524:849-855, 2003.
 
P.25 掲載の参考文献
1) Sakai F, et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997.
PubMed
2) Takeshima T, et al:Population-Based Door-to-Door Survey of Migraine in Japan:The Daisen Study. Headache 44:8-19, 2004.
PubMed
3) Lipton RB, et al:Migraine in the United States:Epidemiology and patterns of health care use. Neurology 58:885-894, 2002.
PubMed
4) Headache Classification Subcommittee of the International Headache Society:The International Classification Of Headache Disorders; 2nd Edition. Cephalalgia 24 (suppl 1):9-160, 2004,
 
5) 竹島多賀夫, 他:慢性頭痛の臨床的検討. 神経内科29:43-52, 1988.
 
6) Swanson J W, et al:Incidence of cluster headaches:a population-based study in Olmsted County, Minnesota. Neurology 44:433-437, 1994.
PubMed
7) Bahra A, et al:Cluster headache:a prospective clinical study with diagnostic implications. Neurology 58:354-361, 2002.
PubMed
8) 竹島多賀夫, 他:慢性頭痛患者のQuality of life (QOL) 第2報 日頭痛会誌26 (1):12-14, 1999.
 
9) Silberstein S D, et al:Classification of daily and near-daily headaches:Field trial of revised IHS criteria. Neurology 47:871-875, 1996.
PubMed
10) Mathew N T:Transformed migraine. Cephalalgia 13 (Suppl) 12:78-83, 1993.
 
11) Terwindt GM, et al:The impact of migraine on quality of life in the general population-The GEM study. Neurology 55:624-629, 2000.
PubMed
12) Seltzer S:Foods, and food and drug combinations, responsible for head and neck pain. Cephalalgia 2:111-124, 1982.
PubMed

第2章 頭痛医療システム

P.32 掲載の参考文献
1) 柿沼 進,他:頭痛専門外来開設に伴う外来受診状況の変化. 神経治療 20:63-69, 2003.
Medical*Online
2) 多田由紀子, 他:頭痛外来開設により受診率が急増した片頭痛患者についての検討. 山口医 52:169-173, 2003.
Medical*Online
3) 根来 清, 他:疫学からみた頭痛の社会的意義 Brain Medical 12:11-19, 2000.
Medical*Online
4) 寺本 純:わが国における片頭痛診療の現状. Medicament News 1713:1-3, 2001.
Medical*Online
5) 寺本 純:頭痛外来のすすめ. 診断と治療 90:844-848, 2002.
Medical*Online
P.39 掲載の参考文献
1) 宮崎東洋:ペインクリニック入門-ペインクリニシャンを目指して-. 真興交易医書 出版部, 東京, 1996.
 
2) 宮崎東洋 編著:神経ブロック関連疾患の整理と手技. 真興交易医書出版部, 東京, 2000.
 
3) 西岡五夫, 他編著:漢方の基礎と応用. 薬事新報社, 東京, 1984.
 
4) 小川節郎編:星状神経節ブロックの生理的意義. 真興交易医書出版部, 東京, 2001.
 
5) 横田敏勝:臨床医のための痛みのメカニズム (改訂第2版). 南江堂, 東京, 2001.
 
P.50 掲載の参考文献
1) 粕谷潤一, 他:激しい頭痛. medicina(増刊号) 35:148-150, 1998.
 
2) 橋本洋一郎, 他:頭部X線CTをキャンセルした頭痛患者. 治療78:1809-1812, 1996.
 
3) 日本神経学会:慢性頭痛治療ガイドライ2002. 臨床神経42:323-362, 2002.
 
4) 橋本洋一郎, 他:脳卒中の診療体制-地域完結型-. 脳卒中23:364-369, 2001.
 
5) 橋本洋一郎, 他:脳卒中における地域完結型リハビリテーション. リハ医39:416-427, 2002.
 
6) 平野照之, 他:地域完結型脳卒中診療態勢-熊本市神経内科関連3施設の虚血性脳血管障害診療状況-. 脳卒中24:201-207, 2002.
 
7) 橋本洋一郎, 他:急性期病院から回復期リハ病棟への期待と注文. 回復期リハビリテーション病棟新しいシステムと運営のしかた, 日本リハビリテーション病院. 施設協会, (全国回復期リハビリテーション病棟連絡協議会編集), p 114-123. 三輪書店, 東京2003
 
8) 信友浩一:医療経済の視点. 内科臨床研修指導マニュアル (社団法人日本内科学会認定内科専門医会 編集), p 239-243. 日本内科学会, 2001.
 
9) 日本医師会:あなたの健康を守るために. 国民健康読本. 日医師会誌127 (3):28-31 (付録), 2002.
 
10) 田坂佳千:地域医療.在宅医療. 内科臨床研修指導マニュアル (社団法人日本内科学会認定内科専門医会 編集), p 128-138. 日本内科学会, 2001.
 
11) Lipton RB, et al:Why headache treatment fails. Neurology 60:1064-1070, 2003.
PubMed
12) 橋本洋一郎, 他:プライマリー・ケアと頭痛医療と病診連携.慢性頭痛の診療ガイドライン作成に関する研究班 平成15年度報告書 (印刷中)
 
P.55 掲載の参考文献
1) Abu-Arefeh I, et al:Prevalence of headache and migraine in school children. BMJ 309:765-769, 1994.
PubMed
2) Raieli V, et al:Migraine headache in adolescents:a student population-based study in Monreale. Cephalalgia 15:5-12, 1995.
PubMed
3) Sakai F, et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997.
PubMed
4) Hu XH, et al:Burden of migraine in the United States:disability and economic costs. Arch Intern Med 159:813-818, 1999.
PubMed
5) Edmeads J, et al:The economic impact of migraine:an analysis of direct and indirect costs. Headache 42:501-509, 2002.
PubMed
6) Mushet G R, et al:Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache 36:137-143, 1996.
PubMed
7) Powers S W, et al:Quality of life in childhood migraines:clinical impact and comparison to other chronic illnesses. Pediatrics 112:1-5, 2003.
PubMed
8) Larsson B, et al:Swedish school nurses:View of school health care utilization, causes and management of recurrent headaches among school children. Scand J Caring Sci 17:232-238, 2003.
PubMed
9) Winner P, et al:Demographic and migraine characteristics of adolescents with migraine:Glaxo Wellcome clinical trials:database. Headache 43:451-457, 2003.
PubMed
10) 藤田光江, 他:小児慢性反復性頭痛の研究第3編:起立性調節障害の頭痛について. 日児誌99:520-526, 1995.
 
P.63 掲載の参考文献
1) Sakai F, et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997.
PubMed
2) Shimomura T, et al:Prevalence of migraine in western Japan. Cephalalgia 13 (Suppl 13):10, 1993.
 
3) Takeshima T, et al:Population-based door-to-door survey of migraine in Japan. Headache 44:8-19, 2004.
PubMed
4) Lipton RB, et al:An update on the epidemiology of migraine. Headache 34:319-328, 1994.
PubMed
5) Rasmussen B K:Epidemiology of headache. Cephalalgia 15:45-68, 1995.
PubMed
6) Stewart W F, et al:Migraine prevalence:a review of population-based studies. Neurology 44 (Suppl 4):S17-S23, 1994.
 
7) Edmeads J, et al:The economic impact of migraine:an analysis of direct and indirect costs. Headache 42:501-509, 2002.
PubMed
8) International Classification of Headache Disorders 2nds Edition (ICHD-II). 24 (Suupl 1):9-160, 2004.
 
9) Ikeda K, et al:Cerebral atherosclerosis and coronary calcification. Stroke 33:2345-2346,
PubMed
10) Evans R W, et al:Migraine classification, diagnostic criteria, and testing. 60 (Suppl 2):S24-S30, 2003. Neurology
 
11) Bruyn G W:Intracranial arteriovenous malformation and migraine. Cephalalgia 4:191-207, 1984.
PubMed
12) Ikeda K, et al:Current incidence of primary brain tumors in Japanese adulthood:brain checkup-based Evidence. Ann Neurol 52 (Suppl 1):S78, 2002.
 
13) Ikeda K, et al:Relative pupil-sparing third nerve palsy:etiology and clinical variables predictive of a mass. Neurology 57:1741-1742, 2001.
PubMed
P.72 掲載の参考文献
1) 坂井文彦, 他:日本版片頭痛クオリティオブライフ調査書(MSQ)の信頼性と妥当性, 神経治療 (近刊).
 
2) 片頭痛 HRQol調査研究グループ (研究代表者 坂井文彦):「片頭痛患者に対する医療経済学的調査報告書」2001.
 
3) 清水文彦, 他:片頭痛におけるスマトリプタン錠の医療経済学的検討. 診療と新薬38. 9, 2001.
 
4) Rapoport A M, et al:Cost of Migraine Management:A Pharmacoeconomic Overview. Am J Manag Care 4:531-545, 1998. Coukell A J, et al:Sumatriptan. A Pharmacoeconomics Review of its Use in Migraine. Pharmacoeconomics 11 (5):473-490, 1997.
 
5) Evans K W, et al:Economic Evaluation of Oral Sumatriptan Compared with Oral Caffeine/Ergotamine for Migraine. Pharmacoeconomics 12 (5):565-577, 1997.
PubMed
6) Sakai E et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997.
 
7) 労働省 (現 厚生労働省) 政策調査部編:平成10年度版「賃金センサス」. (財) 労働法令協会.
 
8) Drummond M E et al:Methods for the Economic Evaluation of Health Care Programs, 2nd ed. p 96-231. Oxford Medical Publication, Oxford, 1997.
 
9) Ikeda S, et al:on behalf of Japanese Euro Qol Tariff Project Health status in Japan:Results from Japanese Euro Qol study. 医療と社会9 (3):83-92, 1999.
 

第3章 頭痛の問診と診察

P.80 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society:The International Classification of Headache Disorders.2nd Edition. Cephalalgia 24 (suppl 1), 2004.
 
2) 寺本 純:頭痛. 改訂第2版. 診断と治療社, 東京, 2000.
 
3) Ekbom K A:A clinical comparison of cluster headache and migraine. Acta Neurol Scand(suppl)46:1-48, 1970.
 
4) 寺本 純:頭痛外来のすすめ. 診断と治療 90:844-848, 2002.
Medical*Online
P.92 掲載の参考文献
1) 岩田 誠監修:ADDITUS Japan. 2001.
 
2) Headache classification of the International Headache Society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (suppl 7):1-96, 1988.
 
3) Stewart W F, et al:Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache related disability. Neurology 56 (Suppl 1):S20-28, 2001.
 
4) Iigaya M, et al:Reliability and Validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache 43:343-352, 2003.
PubMed
5) Otsuka N, et al:Assessment of the effects of triptans on migraine in Japan using the MIDAS Questionnaire. (in Press)
 
6) 五十嵐 (浅倉) 久佳:頭痛患者への指導の重要性. 医事新報 4089:17-22, 2002.
 
7) Sakai F, et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997.
PubMed
8) Lipton R B, et al:Medical consultation for migraine:results from the American Migraine Study. Headache 38:87-96, 1998.
PubMed
9) Edmeads J:Communication issues in migraine diagnosis. Can J Neurol Sci 29 (Suppl 2):S8-10, 2002.
 
P.100 掲載の参考文献
1) 平井俊策:頭痛薬の種類と使い方. Clin Neurosci 15:1033-1035, 1997.
 
2) 内野 誠:頭痛. 総合臨 52:3161-3168, 2003.
Medical*Online
3) 松本典子, 他:脳動脈解離と脳梗塞脳梗塞の診断と治療 (内野 誠監修). p 188-194, 診療新社, 大阪, 1999.
 
4) 中島 誠, 他:体位変換により変化しない頭痛を呈した特発性頭蓋内圧低下症の1例. 脳神経 54:991-995, 2002.
 

第4章 片頭痛

P.108 掲載の参考文献
1) Headache Classification Committee of the International Headache Society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7):1-96, 1988.
 
2) 頭痛研究会:頭痛, 頭蓋神経痛, 顔面痛の分類及び診断基準. 第18回頭痛研会誌 18:91-102, 1991.
 
3) Olesen J:ICHD-II:the new IHS classification of headaches. Cephalalgia 23:567, 2003.
 
4) Headache Classification Subcommittee of the International Headache Society:The International Classification of headache disorders, 2nd Edition. Cephalalgia 24 (Suppl 1):1-160, 2004.
 
5) 間中信也:International Classification of Headache Disorders 2nd Edition (ICHD-II) 国際頭痛分類第二版翻訳案. 厚生労働省慢性頭痛治療ガイドライン作成に関する研究班 平成15年度第二回研究班会議資料:1-106, 2004.
 
P.118 掲載の参考文献
1) Bartsch T, et al:The trigeminocervical complex and migraine:current concepts and synthesis. Curr Pain Headache Rep 7:371-376, 2003.
PubMed
2) Bahra A, et al:Brainstem activation specific to migraine headache. Lancet 357:1016-1017, 2001.
PubMed
3) Burstein R, et al:An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624, 2000.
PubMed
4) Burstein R, et al:Defeating migraine pain with triptans:A race against the development of cutaneous allodynia. Ann Neurol 55:19-26, 2004.
 
5) 濱田潤一:片頭痛の病態仮説. 神研の進歩 46:361-375, 2002.
 
6) 有田秀穂:セロトニン神経系-update (2). 片頭痛とスマトリプタン. Clin Neurosci 21 (4):488-489, 2003.
 
7) 鈴木則宏:片頭痛の発生機序と新しい治療. 脳と神 52:287-295, 2000.
 
8) Olesen J, et al:Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol 9:344-352, 1981.
PubMed
9) Moskowitz M A:The neurobiology of vascular head pain. Ann Neurol 16:157-168, 1984.
PubMed
10) 荒木信夫:片頭痛. 病態生理. 日内会誌90:589-594, 2001.
 
11) Goadsby P J, et al:Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193-196, 1988.
PubMed
12) 竹島多賀夫, 他:片頭痛とセロトニン. Clin Neurosci 21:676-678, 2003.
 
13) Peroutka S J:Migraine:A chronic sympathetic nervous system disorder. Headache 44:53-64, 2004.
 
14) Gotoh F, et al:Noradrenergic nervous system activity in migraine. Arch Neurol 41:951-955, 1984.
PubMed
15) 福内靖男:片頭痛と血管作動物質. 日頭痛会誌25:1-9, 1998.
 
16) Montagna P:Molecular genetics of migraine headache:A review. Cephalalgia 20:3-14, 2000.
PubMed
17) 古和久典, 他:片頭痛と遺伝. Prog Med 21:25-29, 2001.
Medical*Online
18) Ophoff R A, et al:Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+channel gene CACNLIA4. Cell 87:543-552, 1996.
 
19) Terwindt G M, et al:Variable clinical expression of mutations in the P/Q type calcium channel gene in familial hemiplegic migraine. Neurology 50:1105-1110, 1998.
 
20) De Fusco M, et al:Haploinsufficiency of ATP1A2 encoding the Na+/K+pump alpha 2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192-196, 2003.
 
21) Estevez M, et al:Update on the genetics of migraine. Hum Genet 114:225-235, 2004.
PubMed
P.126 掲載の参考文献
1) 濱田潤一:片頭痛の病態仮説. 神経進歩46:361-375, 2002.
 
2) Ferrari M D, et al:On serotonin and migraine:a clinical and pharmacological review. Cephalalgia 13:151-165, 1993.
 
3) Goadsby P J:The pharmcology of headache. Prog Neurobiol 62:509-525, 2000.
 
4) Graham J R, et al:Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatr 39:737-763, 1938.
 
5) Sicuteri F, et al:Biochemical investigation in headache:increase in the hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy 19:55-58, 1961.
 
6) Curran D A, et al:Total plasma serotonin, 5-hydroxyaindoleacetic acid and phydroxym-methxymandelic acid excretion in normal and migrainous subjects. Brain 88:997-1010, 1965.
 
7) Kimball R W, et al:Effect of serotonin in migraine patients. Neurology 10:107-111, 1960.
PubMed
8) 濱田潤一:片頭痛の病態生理と治療-最近の進歩. 神経治療 18:457-461, 2001.
Medical*Online
9) Moskowitz MA:The neurobiology of vascular head pain. Ann Neurol 16:157-168, 1984.
PubMed
10) Hoyer D, et al:International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203, 1994.
PubMed
11) Saxena P R, et al:From serotonin receptor classification to the antimigraine drug sumatriptan. Cephalalgia 12:187-196, 1992.
 
12) Humphrey P P, et al:GR43175, a selective agonist for the 5-HT1-like receptor in dog saphenous vein. Br J Pharmacol 94:1123-1132, 1988.
PubMed
13) Johnson K W, et al:Serotonin in migraine:theories, animal models and emerging therapies. Prog Drug Res 51:219-244, 1998.
PubMed
14) Ramadan N M, et al:5-HT 1F agonists in acute migraine treatment:ahypothesis. Cephalalgia 23:776-785, 2003.
 
15) Goadsby P J, et al:Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5-HT 1B/1D receptor:A central action in migraine? Ann Neurol 43:711-718, 1998.
 
16) Levy D, et al:Disruption of communication between peripheral and central trigemino-vascular neurons mediates the antimigraine action of 5-HT 1B/1D receptor agonists. Proc Natl Acad Sci USA 101:4274-4279, 2004.
 

急性期治療の手順 :

P.134 掲載の参考文献
1) 慢性頭痛治療ガイドライン作成小委員会, 坂井文彦他:日本神経学会治療ガイドライン 慢性頭痛治療ガイドライン2002. 臨神経 42(4):330-362, 2002.
 
2) Stewart W F, et al:An international study to assess reliability of the Migraine Disability Assessment(MIDAS)score. Neurology 53:988-994, 1999.
 
3) 飯塚高浩他:片頭痛の治療:最近の進歩. 日内会誌93 (2) 1198-205, 2004.
 
4) Lipton R B:Disability assessment as a basis for stratified care. Cephalalgia 18 (suppl 22):40-43, 1998.
 
5) 柴田興一:片頭痛の概念と分類. 片頭痛へのアプローチ (坂井文彦 編), p 68-79. 先端医学社, 東京, 2004.
 
6) Dowson A J, et al:Establishing principles for migraine management in primary care. Int J CIin Pract 57 (6):493-507, 2003.
 
7) 岩田 誠:片頭痛治療薬の使い方. 頭痛診療のコツと落とし穴 (坂井文彦 編), p 130-131. 中山書店, 東京, 2003.
 
8) Tfelt-Hansen P, et al:Ergotamine in the acute treatment of migraine:a review and European consensus. Brain 123:9-18, 2000.
 
P.142 掲載の参考文献
1) Ferrari M D, et al:Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:a meta-analysis of 53 trials. Lancet 358 (9294):1668-1675, 2001.
 
2) 慢性頭痛治療ガイドライン作成小委員会:日本神経学会治療ガイドライン, 慢性頭痛治療ガイドライン2002. 臨神経42:330-362, 2002.
 
3) 坂井文彦, 他:コハク酸スマトリプタン (GW102)の後期第II相臨床試験-片頭痛患者を対象としたプラセボとの二重盲験比較試験-. 臨医薬17:1163-1187, 2001.
 
4) Dowson A J, et al:Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22:101-105, 2002.
PubMed
5) Eletriptan Steering Committee in Japan:Efficacy and safety of eletriptan 20mg, 40mg and 80mg in Japanese migraineurs. Cephalalgia 22:416-423, 2002.
 
6) Goadsby P J, et al:Migraine-current understanding and treatment. N Engl J Med 346:257-270, 2002.
PubMed

第5章 緊張型頭痛

P.152 掲載の参考文献
1) 平田幸一:慢性頭痛の診断と初期対応. 痛みと臨2:9-19, 2002.
 
2) 平田幸一, 他:EBMに基づく慢性頭痛の治療. 神研の進歩46:413-430, 2002.
 
3) 日本神経学会治療ガイドライン:慢性頭痛治療ガイドライン2002. 臨神経42:348-354, 2002.
 
4) Headache Classification Committee of the International Headache Society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. of headache. Cephalalgia 8(suppl 7):1-96, 1988.
 
5) Headache Classification Committee of the International Headache Society:The international classification of headache disorders, 2nd edition. Cephalalgia 24 (suppl 1):1-160, 2004.
 
6) Langemark M, et al:Pericranial tendemess in tension headache. A blind, controlled study. Cephalalgia 7:249-255, 1987.
 
7) Bendtsen L, et al:Pressure-controlled palpation:anew technique which increases there liability of manual palpation. Cephalalgia 15:205-210, 1995.
 
8) Jensen R, et al:Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 52:193-199, 1993.
PubMed
9) Jensen R:Pathophysiological mechanisms of tension-type headache:a review of epidemiological and experimental studies. Cephalalgia 19:602-621, 1999.
 
10) Sakai F, et al:Pericranial muscle hardness in tension-type headache. A non-invasive-measurement method and its clinical application. Brain 118:523-531, 1995.
PubMed
11) Ashina M, et al:Muscle hardness in patients with chronic tension-type headache:relation to actual headache state. Pain 79:201-205, 1999,
PubMed
12) Ashina M, et al:Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 122:1629-1635, 1999.
PubMed
13) Ashina M, et al:Effect of inhibition of nitric oxide synthase on chronictension-type headache:a randomised crossover trial. Lancet 353:287-289, 1999.
PubMed
14) Storer R J, et al:Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamatereceptors. Neuroscience 90:1371-1376, 1999.
 
15) 竹島多賀夫, 他:血管性頭痛と緊張型頭痛の一元論. 臨床医22:68-71, 1996.
 
16) Okada H, et al:Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache 38:39-42, 1998.
PubMed
17) Schoenen J, et al:Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology 37:1834-1836, 1987.
PubMed
P.158 掲載の参考文献
1) Headache Classification subcommittee of the International Headache Society:The International Classification of Headache Disorders. 2nd ed. Cephalalgia 24(suppl 1):1-160, 2004
 
2) 作田学:Primary Care Note 頭痛. 日本医事新報社, 東京, 2004.
 
3) 作田学:慢性筋収縮性頭痛における, うつむき姿勢と頸椎支持性の及ぼす影響. 臨床神経30:254-261, 1990.
 

第6章 群発頭痛

P.165 掲載の参考文献
1) Mollendorff:uber hemikranie. Virchows Arch. Path. Anat. 41:385-395, (1867)
 
2) Bing R:Uber traumatische erythromelalgie und erthroprosopalgie. Nervenarzt 3:506-512, 1930.
 
3) Harris W:Ciliary (migrainous) neuralgia and its treatment. Br Med J 1:457-460, 1936.
 
4) Horton B T:histamic cephalalgia. Lancet 2:92-98, 1952.
 
5) Kunkle E C, et al:Reccurent brief headache in cluster pattern. Transactios of the American Neurological Association 77:240-243, 1952.
 
6) Ad Hoc Committee on classification:Classification of headache. Arch Neurol 6:173-176, 1962.
 
7) Headache Classification Committee of the International Headache Society. Cephalalgia 8:1-96, 1988.
 
8) Headache Classification Committee of the International Headache Society:The International Classification of Headache disorders. Cephalalgia 24 (Suppl 1):1-160, 2004.
 
9) Sjaastad O, et al:A new (?) clinical headache entity"chronic paroxysmal hemicrania" 2. Acta Neurol Scand 54:140-159, 1976.
PubMed
10) 上津原甲一, 他:動脈瘤と解離による頭痛. Brain Medical 12:70-77, 2000.
 
11) 上津原甲一:症候性頭痛-外科的疾患. 診断と治療90:941-945, 2002.
 
P.172 掲載の参考文献
1) 鈴木則宏:群発頭痛とその近縁疾患. Annu Rev神経2002:281-290, 2002.
 
2) 荒木信夫:片頭痛・群発頭痛の病態と発生機序. 医薬ジャーナル36:3054-3060, 2000.
 
3) Headache Classification Subcommittee of the International Headache Society:The international classification of headache disorders:2nd edition. Cephalalgia 24 (Suppl 1):9-160, 2004.
 
4) Ekbom K, et al:Carotid angiography in cluster headache. Acta Radiol Diagn 10:177-186, 1970.
PubMed
5) Moskowitz M A:Cluster headache:evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache 28:584-586, 1988.
PubMed
6) Suzuki N, et al:Anatomical basis for a parasympathetic and sensory innervation of the intracranial segment of the internal carotid artery in man. J Neurol Sci 104:19-31, 1991.
 
7) 鈴木則宏:血管性頭痛の病態と治療-レセプターメカニズムとその治療への応用を中心に-. ペインクリニック 21:683-693, 2000.
 
8) The Sumatriptan Cluster Headache Study Group:Treatment of acute cluster headache with sumatriptan, New Engl J Med 325:322-326, 1991.
 
9) Goadsby P J, et al:A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 120:193-209, 1997.
PubMed
10) Drummond P D, et al:Mechanism of normal and abnormal facial flushing and sweating. In Clinical Autonomic Disorders 2nd ed. (edited by Low PA), p 715-726. Lippincott-Raven Publishers, Philadelphia, 1997.
 
11) May A, et al:Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 5:836-838, 1999.
 
P.181 掲載の参考文献
1) 坂井文彦,他:日本神経学会治療ガイドライン.慢性頭痛治療ガイドライン 2002.IV群発頭痛.臨神経 42:355-359,2002.
 
2) Sumatriptan Cluster Headache Study Group:Treatment of acute cluster headache with sumatriptan. N Engl J Med325:322-326,1991.
 
3) Hardebo JE:Subcutaneous sumatriptan in cluster headache:a time study of the effect on pain and autonomic symptoms.Headache 33:18-21,1993.
PubMed
4) 坂井文彦,他:SN-308(Sumatriptan)皮下注射液の第III相臨床試験-群発頭痛患者を対象としたプラセボ注射液との二重盲検比較試験-.臨医薬 16:301-323,2000.
 
5) Van Vliet JA,et al:Internasal sumatriptan in cluster headache:randomised placebo-controlled double-blind study.Neurology 60:630-633,2003.
 
6) Bahra A,et al:Oral zolmitriptan is effective in the acute teatment of cluster headache.Neurology 54:1832-1839,2000.
 
7) Mulder LJ, et al:Naratriptan in the preventive treatment of cluster headache.Cephalalgia 22:815-817,2002.
PubMed
8) Kudrow L:Response of cluster headache attacks to oxygen inhalation.Headache 21:1-4,1981.
PubMed
9) Robbins L:Intranasal lidocaine for cluster headache.Headache 35:83-84,1995.
PubMed
10) 清水俊彦:群発頭痛.Brain Med 12:58-64,2000.
Medical*Online
11) 金浩澤:特異的治療法-マグネシウム静注治療の効果と作用機序-.日頭痛会誌 29:25-28,2002.
 
12) Kudrow L:Cluster headache:mechanisms and management. Oxford University Press,New York,1980.
 
13) Mir P, et al:Prophylactic treatment of episodic cluster headache with intravenous bolus of methylpredonisolone. Neurol Sci 24:318-321,2003.
 
14) Lenaerts ME:Cluster headache and cluster variants. Curr Treat Options Neurol 5:455-466,2003.
PubMed
15) Bussone G, et al:Double blind comparison of lithium and verapamil in cluster headache prophylaxis.Headache 30:411-417,1990.
PubMed
16) Wheeler S:Significance of migrainous features in cluster headache:divalproex responsiveness.Headache 53:234-236,1998.
 
17) Lainez MJA, et al:Topiramate in the prophylactic treatment of cluster headache.Headache 43:784-789,2003.
 
18) Jarrar RG, et al: Outcome of trigeminal nerve section in the treatment of chronic cluster headache.Neurology 60:1360-1362,2003.
PubMed
19) Ford RG, et al:Gamma knife treatment of refractory cluster headache. Headache 38:3-9,1998.
PubMed
20) Leone M, et al:Hypothalamic deep brain stimulation for intractable chronic cluster headache:a 3-year follow-up. Neurol Sci 24:S143-S145,2003.
PubMed

第7章 薬物乱用頭痛

P.192 掲載の参考文献
1) Headache Classification Committee of the international Headache Society:International Classification Of Headache Disorders 2nd Edition (ICHD-II). Cephalalgia 24 (Suppl 1):9-160, 2004.
 
2) Headache Classification Committee of the International Headache Society:Medication-overuse headache (MOH). Cephalalgia 24 (Supple 1):94-95,2004.
 
3) 竹島多賀夫, 他:慢性副鼻腔炎による頭痛.クリニシアン 50巻9-10:906-910, 2003.
 
4) 清水俊彦:片頭痛マネジメントの将来. 脳21 6 (No. 1):79-86, 2003.
 
5) Michael R et al:Headaches Associated with Medical Diseases. Headache:233-237, 1993.
 
6) Murialdo G, et al:Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone in common migraine. Cephalalgia 7:267-272, 1987.
PubMed
7) 岡明:慢性頭痛. 小児臨54 (No.. 4):695-698, 2001.
 
8) 藤田光江:小児の片頭痛. Pharm Med 20 (No. 7):47-53, 2002.
 
9) 関 秀俊:小児慢性反復性頭痛の臨床的分類の検討. 金沢大保健紀24 (No. 2):167-170, 2000.
 
10) 清水俊彦:女性と片頭痛. Medical ASAHI:55-60, 2002.
 
11) 大石 実:薬剤誘発性頭痛. 臨床と研究79巻10号:79-81, 2003.
 
12) 平田幸一:慢性連日性頭痛. 診断と治療90 (No. 6):889-895, 2002.
 
13) Alan M, et al:Headache Associated with Medication and Substance Withdrawal. Headache:227-231, 1993.
 
14) 濱田潤一:片頭痛の病態仮説. 神経研究の進歩46:361-375, 2002.
 
15) 竹島多賀夫他:トリプタン系頭痛薬.治療学 36:69-76, 2002.
 
16) 鈴木則宏:片頭痛の発生機序と新しい治療. 脳と神52:287-295, 2000.
 

第8章 頭痛治療のガイドライン

P.199 掲載の参考文献
1) 中村清吾:診断ガイドラインでさがす. EBMジャーナル1:46-49, 2000.
 
2) 日本神経学会治療ガイドラインAd Hoc委員会:慢性頭痛治療ガイドライン2002. 臨床神経42:332-362, 2002.
 
3) Institute of Medicine:Clinical Practice Guideness:Directions for a New Program. National Academy Press, Washington DC, 1990.
 
4) Silberstein S D, et al:Classification of daily and near-daily headaches:proposed divisions to the IHS criteria Headache 34:1-7, 1994.
 

書評

最近チェックした商品履歴

Loading...